Search research articles
Contact Us
Filters
Showing results (11-20 of 24) with videos related to
Page
of 3
Sort By:
Presse Medicale (Paris, France : 1983)
|
February 1, 2002
[Typhoid cerebellitis]
C Aubron, P Camara, T Passeron, et al.
Presse Medicale (Paris, France : 1983)
|
April 25, 2001
[Symptomatic subcutaneous iliac empyema in lumbar Pott's disease]
P Hovette, F Simon, C Aubron, et al.
Epidemiology and Infection
|
April 26, 2014
The epidemiology of bacteriuria and candiduria in critically ill patients
C Aubron, S Suzuki, N J Glassford, et al.
AIDS (London, England)
|
January 5, 2002
Successful control of subfulminant hepatitis related to lamivudine-resistant hepatitis B virus in an HIV-infected patient
D Thabut, V Thibault, Y Benhamou, et al.
Medecine Tropicale : Revue Du Corps De Sante Colonial
|
October 5, 2001
[Value of Quantitative Buffy Coat (QBC) in borreliasis-malaria co-infection]
P Hovette, C Aubron, J D Perrier-Gros-Claude, et al.
The Journal of Hospital Infection
|
December 7, 2010
High level cephalosporin-resistant Enterobacteriaceae ventilator-associated pneumonia: prognostic factors based on a cohort study
C Aubron, A Chaari, R Bronchard, et al.
Transfusion Clinique Et Biologique : Journal De La Societe Francaise De Transfusion Sanguine
|
June 25, 2018
Compliance with the European trauma guidelines: An observational single centre study
Y Rossignol, O Huet, X Chapalain, et al.
The Journal of Antimicrobial Chemotherapy
|
February 29, 2012
Resistance profiles of emtricitabine and lamivudine in tenofovir-containing regimens
A G Marcelin, C Charpentier, M Wirden, et al.
The Journal of Antimicrobial Chemotherapy
|
January 8, 2010
Switching the nucleoside reverse transcriptase inhibitor backbone to tenofovir disoproxil fumarate + emtricitabine promptly improves triglycerides and low-density lipoprotein cholesterol in dyslipidaemic patients
M A Valantin, R Bittar, P de Truchis, et al.
Vox Sanguinis
|
February 3, 2018
Day or overnight transfusion in critically ill patients: does it matter?
C Aubron, R K Kandane-Rathnayake, N Andrianopoulos, et al.
Page
of 3
Search research articles
Search
Showing results (11-20 of 24) with videos related to
Sort By:
Page
of 3
Presse Medicale (Paris, France : 1983)
|
February 1, 2002
[Typhoid cerebellitis]
C Aubron, P Camara, T Passeron, et al.
Presse Medicale (Paris, France : 1983)
|
April 25, 2001
[Symptomatic subcutaneous iliac empyema in lumbar Pott's disease]
P Hovette, F Simon, C Aubron, et al.
Epidemiology and Infection
|
April 26, 2014
The epidemiology of bacteriuria and candiduria in critically ill patients
C Aubron, S Suzuki, N J Glassford, et al.
AIDS (London, England)
|
January 5, 2002
Successful control of subfulminant hepatitis related to lamivudine-resistant hepatitis B virus in an HIV-infected patient
D Thabut, V Thibault, Y Benhamou, et al.
Medecine Tropicale : Revue Du Corps De Sante Colonial
|
October 5, 2001
[Value of Quantitative Buffy Coat (QBC) in borreliasis-malaria co-infection]
P Hovette, C Aubron, J D Perrier-Gros-Claude, et al.
The Journal of Hospital Infection
|
December 7, 2010
High level cephalosporin-resistant Enterobacteriaceae ventilator-associated pneumonia: prognostic factors based on a cohort study
C Aubron, A Chaari, R Bronchard, et al.
Transfusion Clinique Et Biologique : Journal De La Societe Francaise De Transfusion Sanguine
|
June 25, 2018
Compliance with the European trauma guidelines: An observational single centre study
Y Rossignol, O Huet, X Chapalain, et al.
The Journal of Antimicrobial Chemotherapy
|
February 29, 2012
Resistance profiles of emtricitabine and lamivudine in tenofovir-containing regimens
A G Marcelin, C Charpentier, M Wirden, et al.
The Journal of Antimicrobial Chemotherapy
|
January 8, 2010
Switching the nucleoside reverse transcriptase inhibitor backbone to tenofovir disoproxil fumarate + emtricitabine promptly improves triglycerides and low-density lipoprotein cholesterol in dyslipidaemic patients
M A Valantin, R Bittar, P de Truchis, et al.
Vox Sanguinis
|
February 3, 2018
Day or overnight transfusion in critically ill patients: does it matter?
C Aubron, R K Kandane-Rathnayake, N Andrianopoulos, et al.
Page
of 3